image

The best stocks to buy since 1993

Latest issue now available

Growth Portfolio 2 - November

November 2006

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Quite a good month for the universe of companies we cover in Sharewatch. An incredible number of 52-week highs including May Gurney, Scott Wilson, Spice, Caretech, Zenith and Wilmington. Most of these are working out to be nice gentle plodders which have developed bottom-left-top-right charts. Overall, the Portfolio outperformed both the FTSE-100 and the All Share by a comfortable margin. The other new high was, of course, Renesola. It’s incredible to see upgrades again, for the second time in as many months, with the latest forecasts included elsewhere in this newsletter. The obvious problem here, of course, is that this has grown in everyone’s mind to be the most stunning, amazing company ever and those expectations ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER

SUBSCRIBE TODAY AND SAVE £40 WITH OFFER CODE 40OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe